Close Menu

NEW YORK (GenomeWeb) – IsoPlexis said today that it has raised $25 million in a Series C financing round.

The round was led by Northpond Ventures and included what the company called "new strategic investment," as well as funds from current investors Spring Mountain Capital, Ironwood Capital, North Sound Capital, and Connecticut Innovations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.